Unison Clinical Trials
Welcome,         Profile    Billing    Logout  
 1 Trial 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Vega, Carlos Gonzalez de
NCT04800562: A Clinical Trial to Evaluate PCS499 in Treating Ulcerations in Patients Who Have Necrobiosis Lipoidica

Terminated
2
4
US
PCS499, placebo
Processa Pharmaceuticals
Necrobiosis Lipoidica
02/23
04/23
NCT06101823: Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis

Active, not recruiting
2
48
Canada, US
OpSCF, Placebo, OpSCF (Open Label Extension)
Opsidio, LLC, Innovaderm Research Inc.
Atopic Dermatitis
10/24
06/25
Jacobs, Shahram
TAK-279-PsO-3003, NCT06550076: A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Recruiting
3
1300
Europe, Canada, Japan, US, RoW
TAK-279
Takeda
Plaque Psoriasis
05/26
05/26
TAK-279-3002, NCT06108544: A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period

Active, not recruiting
3
1108
Europe, Canada, US, RoW
TAK-279, Placebo, Apremilast
Takeda
Plaque Psoriasis
12/24
11/25
Almaraz, Linda
NCT06101823: Phase 2a Study of Efficacy and Safety of OpSCF in Moderate to Severe Atopic Dermatitis

Active, not recruiting
2
48
Canada, US
OpSCF, Placebo, OpSCF (Open Label Extension)
Opsidio, LLC, Innovaderm Research Inc.
Atopic Dermatitis
10/24
06/25
Lopez-Vargas, Joanna
No trials found

Download Options